brivaracetam Briviact
Selected indexed studies
- Brivaracetam. (, 2012) [PMID:31643850]
- Brivaracetam. (Aust Prescr, 2017) [PMID:28798518]
- Brivaracetam (Briviact) for epilepsy. (Med Lett Drugs Ther, 2016) [PMID:27403785]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Brivaracetam. (2012) pubmed
- Brivaracetam. (2017) pubmed
- Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy. (2024) pubmed
- PMID:28846216 (2017) pubmed
- Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review. (2021) pubmed
- Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial. (2024) pubmed
- Brivaracetam (Briviact) for epilepsy. (2016) pubmed
- Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update. (2018) pubmed
- Brivaracetam (Briviact): A Novel Adjunctive Therapy for Partial-Onset Seizures. (2017) pubmed
- Brivaracetam: First Global Approval. (2016) pubmed